| LOOMIS SAYLES GLOBAL GROWTH EQUITY R/A (USD) | RVI GLOBAL CRECIMIENTO | -3,47% | 46,90% | 35,39% | 177,35% |
| AB SICAV I-GLOBAL CORE EQUITY PORTFOLIO A USD | RVI GLOBAL | 15,44% | 41,70% | 35,38% | 143,20% |
| BNP PARIBAS EMERGING EQUITY CLASSIC USD CAP | RVI EMERGENTES | 26,55% | 71,76% | 35,37% | 64,54% |
| BROWN ADVISORY GLOBAL LEADERS A USD ACC | RVI GLOBAL | 5,18% | 36,97% | 35,37% | · |
| CT (LUX) PAN EUROPEAN EQUITIES 8E EUR | RVI EUROPA | 9,33% | 42,58% | 35,37% | · |
| MULTIUNITS LUX - AMUNDI MSCI WORLD HEALTH CARE UCITS ETF ACC EUR | RVI SALUD | 20,75% | 23,16% | 35,37% | 140,02% |
| CT (LUX) PAN EUROPEAN EQUITIES 8G GBP | RVI EUROPA | 9,31% | 42,24% | 35,36% | · |
| NOMURA FUNDS IRELAND - AMERICAN CENTURY EMERGING MARKETS TRANSITION EQUITY FUND I GBP | RVI EMERGENTES | 30,66% | 77,07% | 35,36% | · |
| SCHRODER ISF LATIN AMERICAN A DIS GBP | RVI LATINOAMÉRICA | 36,16% | 27,46% | 35,36% | 35,06% |
| BNP PARIBAS HEALTH CARE INNOVATORS I EUR CAP | RVI SALUD | 13,93% | 28,17% | 35,35% | 138,69% |
